Ching-Yih Lin

977 citations
28 papers · 589 indexed · h-index 16
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers)Cancer-related Molecular Pathways (4 papers)Cancer-related gene regulation (4 papers)

In The Last Decade

Ching-Yih Lin

28 papers receiving 579 citations

Peers

Ching-Yih Lin
Comparison fields: 5 of 103
  • Molecular Biology 245
  • Cancer Research 133
  • Oncology 123
  • Surgery 101
  • Pulmonary and Respiratory Medicine 73
Replace Wenlin Cheng with:
Wenlin Cheng China
John R. Stroehlein United States
Pierre Wacker Switzerland
Kimimasa Ikeda Japan
Luís Sabater Spain
Byung Kee Kim South Korea
Mallika Lala United States
Zhiming Zhao China
Juliane Liese Germany
Dorit Blickstein Israel
Ching-Yih Lin relative to Wenlin Cheng China Wenlin Cheng's profile →
Citations per field
00.5×6.2×
Wenlin Cheng · 1×
Citations per year

Countries citing papers authored by Ching-Yih Lin

Since Specialization
Citations

This map shows the geographic impact of Ching-Yih Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Yih Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Yih Lin more than expected).

Fields of papers citing papers by Ching-Yih Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching-Yih Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Yih Lin. The network helps show where Ching-Yih Lin may publish in the future.

Co-authorship network of co-authors of Ching-Yih Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ching-Yih Lin. A scholar is included among the top collaborators of Ching-Yih Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching-Yih Lin. Ching-Yih Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 28
3 34
4 34
5 2
6 10
7 19
8 35
9 22
10 11
11 15
12 10
13 8
14 27
15 15
16 15
17 4
18 25
19 15
20 7

About Ching-Yih Lin

Ching-Yih Lin is a scholar working on Cancer Research, Family Practice and Oncology, having authored 28 papers that have together received 589 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Cancer-related Molecular Pathways (4 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Endocrinology (73 citations), Cancer Research (133 citations) and Oncology (123 citations). Ching-Yih Lin has collaborated with scholars based in Taiwan, Hong Kong and United States. Frequent co-authors include Chien‐Feng Li, Chung‐Hsi Hsing, Sung-Wei Lee, Hsuan-Ying Huang, Ming-Jen Sheu, Yow-Ling Shiue, Li-Ching Lin, Yu-Feng Tian, Hung-Jen Tang and Li‐Tzong Chen. Their work appears in journals such as Stroke, Emerging infectious diseases and Journal of General Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026